TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Ridgeview Diagnostics AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0 | |
| Financial expenses |
0
|
2 | |
| Earnings before taxes |
-165
|
-328 | |
| EBITDA |
-15
|
-9 | |
| Total assets |
386
|
547 | |
| Current assets |
265
|
305 | |
| Current liabilities |
0
|
1 | |
| Equity capital |
386
|
546 | |
| - share capital |
124
|
124 | |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
100%
|
99.8% | |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-42.7%
|
-59.6% | |
| Current ratio | 30500% | ||
| Return on equity (ROE) |
-42.7%
|
-60.1% | |
| Change turnover |
0
|
-100 | |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.